Company page

Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc. is a public company traded under the ticker 9PT on the German market. The company has a market capitalization of approximately €71.83 million. Pliant focuses on developing innovative therapies for fibrotic diseases, leveraging its expertise in the field to address unmet medical needs.